|
G |
A2M |
alpha-2-macroglobulin |
increases uptake multiple interactions |
EXP |
A2M protein modified form results in increased uptake of Deoxyglucose HSPA5 protein affects the reaction [A2M protein modified form results in increased uptake of Deoxyglucose] |
CTD |
PMID:25720493 |
|
NCBI chr12:9,067,708...9,116,229
Ensembl chr12:9,067,664...9,116,229
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
multiple interactions |
EXP |
Deoxyglucose inhibits the reaction [ABCB1 protein results in increased export of Diazinon] |
CTD |
PMID:16221533 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323 Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCC9 |
ATP binding cassette subfamily C member 9 |
multiple interactions |
ISO |
[Oligomycins co-treated with Deoxyglucose] results in increased activity of [KCNJ11 protein binds to ABCC9 protein]; Glyburide inhibits the reaction [[Oligomycins co-treated with Deoxyglucose] results in increased activity of [KCNJ11 protein binds to ABCC9 protein]] |
CTD |
PMID:28842488 |
|
NCBI chr12:21,797,389...21,941,863
Ensembl chr12:21,797,401...21,942,529 Ensembl chr12:21,797,401...21,942,529
|
|
G |
ABRA |
actin binding Rho activating protein |
multiple interactions increases uptake |
ISO |
CCG 1423 promotes the reaction [ABRA mutant form promotes the reaction [INS1 protein results in increased uptake of Deoxyglucose]]; CCG 1423 promotes the reaction [ABRA mutant form results in increased uptake of Deoxyglucose]; CCG 1423 promotes the reaction [INS1 protein promotes the reaction [ABRA mutant form results in increased uptake of Deoxyglucose]]; INS1 protein promotes the reaction [ABRA mutant form results in increased uptake of Deoxyglucose] |
CTD |
PMID:21393865 |
|
NCBI chr 8:106,759,483...106,809,073
Ensembl chr 8:106,759,483...106,770,244
|
|
G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
multiple interactions increases uptake |
EXP |
Indinavir inhibits the reaction [ADIPOQ protein modified form results in increased uptake of Deoxyglucose] |
CTD |
PMID:29991592 |
|
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
|
|
G |
AGRP |
agouti related neuropeptide |
increases expression |
ISO |
Deoxyglucose results in increased expression of AGRP mRNA |
CTD |
PMID:10683841 |
|
NCBI chr16:67,482,571...67,483,547
Ensembl chr16:67,482,571...67,483,813 Ensembl chr16:67,482,571...67,483,813
|
|
G |
APP |
amyloid beta precursor protein |
multiple interactions |
EXP |
[Sodium Azide co-treated with Deoxyglucose] affects the cleavage of and affects the localization of APP protein |
CTD |
PMID:17405930 |
|
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,550...26,171,128
|
|
G |
ATG3 |
autophagy related 3 |
multiple interactions |
EXP |
Deoxyglucose affects the reaction [demycarosyl-3D-digitoxosylmithramycin SK affects the expression of ATG3 mRNA] |
CTD |
PMID:26079942 |
|
NCBI chr 3:112,532,510...112,561,962
Ensembl chr 3:112,532,510...112,562,046
|
|
G |
ATG4B |
autophagy related 4B cysteine peptidase |
multiple interactions |
EXP |
[demycarosyl-3D-digitoxosylmithramycin SK co-treated with Deoxyglucose] results in increased expression of ATG4B mRNA |
CTD |
PMID:26079942 |
|
NCBI chr 2:241,637,659...241,673,857
Ensembl chr 2:241,637,213...241,673,857
|
|
G |
ATG7 |
autophagy related 7 |
multiple interactions |
EXP |
ATG7 protein inhibits the reaction [Deoxyglucose results in increased cleavage of CASP3 protein]; ATG7 protein inhibits the reaction [Deoxyglucose results in increased expression of DDIT3 protein]; ATG7 protein inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 protein]; ATG7 protein promotes the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein] |
CTD |
PMID:20593179 |
|
NCBI chr 3:11,272,348...11,564,652
Ensembl chr 3:11,272,309...11,557,665
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions decreases expression |
EXP |
Deoxyglucose promotes the reaction [arsenic trioxide results in increased localization of and results in increased activity of BAX protein]; Deoxyglucose results in increased localization of and results in increased activity of BAX protein Deoxyglucose results in decreased expression of BAX mRNA |
CTD |
PMID:23041229 PMID:26079942 |
|
NCBI chr19:48,954,825...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
EXP |
Deoxyglucose affects the reaction [demycarosyl-3D-digitoxosylmithramycin SK affects the expression of BCL2 mRNA] |
CTD |
PMID:26079942 |
|
NCBI chr18:63,123,346...63,320,280
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
decreases response to substance |
ISO |
BCL2L1 protein results in decreased susceptibility to Deoxyglucose |
CTD |
PMID:10679475 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BECN1 |
beclin 1 |
multiple interactions |
EXP |
[bafilomycin A co-treated with Deoxyglucose co-treated with demycarosyl-3D-digitoxosylmithramycin SK] results in decreased expression of BECN1 protein; [demycarosyl-3D-digitoxosylmithramycin SK co-treated with Deoxyglucose] results in increased expression of BECN1 mRNA |
CTD |
PMID:26079942 |
|
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
|
|
G |
BID |
BH3 interacting domain death agonist |
multiple interactions |
EXP |
Deoxyglucose promotes the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of BID protein]; Deoxyglucose results in increased cleavage of and results in increased activity of BID protein |
CTD |
PMID:23041229 |
|
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases activity increases cleavage |
EXP ISO |
ATG7 protein inhibits the reaction [Deoxyglucose results in increased cleavage of CASP3 protein]; Deoxyglucose promotes the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of CASP3 protein]; Deoxyglucose results in increased cleavage of and results in increased activity of CASP3 protein Deoxyglucose promotes the reaction [Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]] Deoxyglucose results in increased activity of CASP3 protein Corticosterone inhibits the reaction [Deoxyglucose results in increased activity of CASP3 protein]; GPX4 protein inhibits the reaction [Deoxyglucose results in increased activity of CASP3 protein] |
CTD |
PMID:10506188 PMID:15755911 PMID:20593179 PMID:23041229 PMID:29095437 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,649,509
|
|
G |
CASP9 |
caspase 9 |
multiple interactions |
EXP |
[Deoxyglucose co-treated with Cisplatin] results in increased activity of CASP9 protein; Deoxyglucose promotes the reaction [Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP9 protein]; Deoxyglucose results in increased cleavage of and results in increased activity of CASP9 protein |
CTD |
PMID:20138251 PMID:23041229 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
multiple interactions |
EXP |
[demycarosyl-3D-digitoxosylmithramycin SK co-treated with Deoxyglucose] results in increased expression of CDKN1A mRNA |
CTD |
PMID:26079942 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,339 Ensembl chr 6:36,676,460...36,687,339
|
|
G |
CHRM3 |
cholinergic receptor muscarinic 3 |
affects response to substance |
ISO |
CHRM3 protein affects the susceptibility to Deoxyglucose |
CTD |
PMID:14724830 |
|
NCBI chr 1:239,386,565...239,915,450
Ensembl chr 1:239,386,565...239,915,452
|
|
G |
CHUK |
component of inhibitor of nuclear factor kappa B kinase complex |
affects localization |
EXP |
Deoxyglucose analog affects the localization of CHUK protein |
CTD |
PMID:27931795 |
|
NCBI chr10:100,188,300...100,229,610
Ensembl chr10:100,188,300...100,229,596
|
|
G |
CTSD |
cathepsin D |
increases expression |
ISO |
Deoxyglucose results in increased expression of CTSD protein |
CTD |
PMID:20026095 |
|
NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,755...1,764,573 Ensembl chr11:1,752,755...1,764,573
|
|
G |
CUL7 |
cullin 7 |
multiple interactions |
ISO |
[INS1 protein co-treated with CUL7 mutant form] results in increased uptake of Deoxyglucose |
CTD |
PMID:24219910 |
|
NCBI chr 6:43,037,617...43,053,945
Ensembl chr 6:43,037,617...43,053,945 Ensembl chr 6:43,037,617...43,053,945
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
multiple interactions increases expression |
EXP |
ATG7 protein inhibits the reaction [Deoxyglucose results in increased expression of DDIT3 protein]; Mannose inhibits the reaction [Deoxyglucose results in increased expression of DDIT3 protein] |
CTD |
PMID:20593179 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
EGFR |
epidermal growth factor receptor |
multiple interactions increases import |
EXP |
AICA ribonucleotide inhibits the reaction [EGFR protein results in increased import of Deoxyglucose] EGFR protein mutant form results in increased import of Deoxyglucose |
CTD |
PMID:19625624 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
EIF4EBP1 |
eukaryotic translation initiation factor 4E binding protein 1 |
multiple interactions |
EXP |
Deoxyglucose results in decreased phosphorylation of and results in increased expression of EIF4EBP1 protein |
CTD |
PMID:23363784 |
|
NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
|
|
G |
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
multiple interactions |
EXP |
[Deoxyglucose co-treated with Quercetin] results in increased ubiquitination of ERBB2 protein; Deoxyglucose inhibits the reaction [Quercetin promotes the reaction [ERBB2 protein binds to HSP90AA1 protein]] |
CTD |
PMID:18655187 |
|
NCBI chr17:39,688,094...39,728,660
Ensembl chr17:39,687,914...39,730,426
|
|
G |
FXYD2 |
FXYD domain containing ion transport regulator 2 |
multiple interactions increases transport |
EXP |
Calcium inhibits the reaction [FXYD2 protein results in increased transport of Deoxyglucose] |
CTD |
PMID:11533133 |
|
NCBI chr11:117,820,057...117,828,089
Ensembl chr11:117,800,844...117,828,698
|
|
G |
GALR1 |
galanin receptor 1 |
increases expression |
ISO |
Deoxyglucose results in increased expression of GALR1 mRNA |
CTD |
PMID:9858361 PMID:9928191 |
|
NCBI chr18:77,249,848...77,277,900
Ensembl chr18:77,249,848...77,277,900 Ensembl chr18:77,249,848...77,277,900
|
|
G |
GCG |
glucagon |
multiple interactions increases secretion |
ISO |
Capsaicin inhibits the reaction [Deoxyglucose results in increased secretion of GCG protein] |
CTD |
PMID:1378463 |
|
NCBI chr 2:162,142,882...162,152,247
Ensembl chr 2:162,142,882...162,152,404
|
|
G |
GPX4 |
glutathione peroxidase 4 |
multiple interactions |
ISO |
GPX4 protein inhibits the reaction [Deoxyglucose results in increased activity of CASP3 protein] |
CTD |
PMID:10506188 |
|
NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,926...1,106,791
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
multiple interactions |
EXP |
Deoxyglucose inhibits the reaction [arsenic trioxide results in increased phosphorylation of GSK3B protein]; Deoxyglucose inhibits the reaction [Fenretinide results in increased phosphorylation of GSK3B protein] |
CTD |
PMID:25246272 |
|
NCBI chr 3:119,821,321...120,095,823
Ensembl chr 3:119,821,323...120,094,417 Ensembl chr 3:119,821,323...120,094,417 Ensembl chr 3:119,821,323...120,094,417
|
|
G |
H2AX |
H2A.X variant histone |
decreases expression |
EXP |
Deoxyglucose results in decreased expression of H2AX protein |
CTD |
PMID:23363784 |
|
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,854...119,095,467
|
|
G |
HK2 |
hexokinase 2 |
multiple interactions |
EXP |
Deoxyglucose results in decreased expression of and results in decreased activity of HK2 protein |
CTD |
PMID:32619556 |
|
NCBI chr 2:74,834,126...74,893,359
Ensembl chr 2:74,834,127...74,893,359 Ensembl chr 2:74,834,127...74,893,359
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions |
EXP |
Deoxyglucose inhibits the reaction [arsenic trioxide results in increased expression of HMOX1 protein]; Deoxyglucose inhibits the reaction [Fenretinide results in increased expression of HMOX1 protein] |
CTD |
PMID:25246272 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,207 Ensembl chr22:35,380,361...35,394,207
|
|
G |
HSP90AA1 |
heat shock protein 90 alpha family class A member 1 |
multiple interactions |
EXP |
Deoxyglucose inhibits the reaction [Quercetin promotes the reaction [ERBB2 protein binds to HSP90AA1 protein]] |
CTD |
PMID:18655187 |
|
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,738...102,139,699 Ensembl chr14:102,080,738...102,139,699
|
|
G |
HSP90B1 |
heat shock protein 90 beta family member 1 |
multiple interactions increases expression |
EXP |
4-Quinolones analog inhibits the reaction [Deoxyglucose results in increased expression of HSP90B1 protein] |
CTD |
PMID:31022492 |
|
NCBI chr12:103,930,410...103,947,926
Ensembl chr12:103,930,107...103,953,645 Ensembl chr12:103,930,107...103,953,645
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions increases expression |
EXP |
4-Quinolones analog inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 mRNA]; 4-Quinolones analog inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 protein]; ATG7 protein inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 protein]; HSPA5 protein affects the reaction [A2M protein modified form results in increased uptake of Deoxyglucose]; HSPA5 protein affects the reaction [INS protein results in increased uptake of Deoxyglucose]; Mannose inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 protein]; Oxygen deficiency inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 protein] Deoxyglucose results in increased expression of HSPA5 mRNA; Deoxyglucose results in increased expression of HSPA5 protein |
CTD |
PMID:20593179 PMID:25720493 PMID:31022492 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,343 Ensembl chr 9:125,234,853...125,241,343
|
|
G |
HTRA2 |
HtrA serine peptidase 2 |
multiple interactions decreases localization |
EXP |
Deoxyglucose promotes the reaction [arsenic trioxide results in decreased localization of HTRA2 protein] Deoxyglucose results in decreased localization of HTRA2 protein |
CTD |
PMID:23041229 |
|
NCBI chr 2:74,529,405...74,533,556
Ensembl chr 2:74,529,725...74,533,332 Ensembl chr 2:74,529,725...74,533,332
|
|
G |
IGF1R |
insulin like growth factor 1 receptor |
multiple interactions |
EXP |
Deoxyglucose results in increased phosphorylation of and results in increased activity of IGF1R protein |
CTD |
PMID:23041229 |
|
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
|
|
G |
IL1B |
interleukin 1 beta |
decreases response to substance multiple interactions |
EXP |
Deoxyglucose results in decreased susceptibility to IL1B protein Deoxyglucose inhibits the reaction [IL1B protein results in increased expression of MMP13 protein] |
CTD |
PMID:21211511 |
|
NCBI chr 2:112,829,751...112,836,843
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
INS |
insulin |
increases uptake multiple interactions |
EXP ISO |
INS protein results in increased uptake of Deoxyglucose; INS results in increased uptake of Deoxyglucose METRNL protein inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]; PPARA protein promotes the reaction [GW 7647 promotes the reaction [INS protein results in increased uptake of Deoxyglucose]] 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]]; 4-phenylbutyric acid inhibits the reaction [Glucosamine inhibits the reaction [INS results in increased uptake of Deoxyglucose]]; Glucosamine inhibits the reaction [INS results in increased uptake of Deoxyglucose]; GW 7647 promotes the reaction [INS protein results in increased uptake of Deoxyglucose]; HSPA5 protein affects the reaction [INS protein results in increased uptake of Deoxyglucose]; Palmitates inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]; Palmitic Acid inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]; SLC2A1 protein inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]; tin protoporphyrin IX inhibits the reaction [3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]]]; TNF protein inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]; Troglitazone inhibits the reaction [TNF protein inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]]; ursodoxicoltaurine inhibits the reaction [Glucosamine inhibits the reaction [INS results in increased uptake of Deoxyglucose]] |
CTD |
PMID:2173694 PMID:16483873 PMID:20165829 PMID:21324916 PMID:25720493 PMID:25815690 PMID:30213948 PMID:31877369 |
|
NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,341 Ensembl chr11:2,159,779...2,161,341
|
|
G |
ITGB1 |
integrin subunit beta 1 |
decreases expression |
EXP |
Deoxyglucose analog results in decreased expression of ITGB1 protein |
CTD |
PMID:27931795 |
|
NCBI chr10:32,900,318...32,958,230
Ensembl chr10:32,900,318...33,005,792 Ensembl chr10:32,900,318...33,005,792
|
|
G |
KCNH2 |
potassium voltage-gated channel subfamily H member 2 |
multiple interactions decreases activity |
EXP |
[Deoxyglucose co-treated with Glucose deficiency] results in decreased activity of KCNH2 protein; Deoxyglucose inhibits the reaction [Glucose results in decreased activity of KCNH2 protein]; Deoxyglucose promotes the reaction [Glucose deficiency results in decreased activity of KCNH2 protein]; Pyruvic Acid inhibits the reaction [[Deoxyglucose co-treated with Glucose deficiency] results in decreased activity of KCNH2 protein] Deoxyglucose results in decreased activity of KCNH2 protein |
CTD |
PMID:12531891 |
|
NCBI chr 7:150,944,956...150,978,321
Ensembl chr 7:150,944,961...150,978,321
|
|
G |
KCNJ11 |
potassium inwardly rectifying channel subfamily J member 11 |
multiple interactions |
ISO |
[Oligomycins co-treated with Deoxyglucose] results in increased activity of [KCNJ11 protein binds to ABCC9 protein]; Glyburide inhibits the reaction [[Oligomycins co-treated with Deoxyglucose] results in increased activity of [KCNJ11 protein binds to ABCC9 protein]] |
CTD |
PMID:28842488 |
|
NCBI chr11:17,385,246...17,389,346
Ensembl chr11:17,385,859...17,389,331 Ensembl chr11:17,385,859...17,389,331
|
|
G |
LEP |
leptin |
multiple interactions decreases secretion |
ISO |
[Deoxyglucose results in decreased abundance of Adenosine Triphosphate] which results in decreased secretion of LEP protein Deoxyglucose results in decreased secretion of LEP protein |
CTD |
PMID:10780946 |
|
NCBI chr 7:128,241,201...128,257,629
Ensembl chr 7:128,241,278...128,257,629
|
|
G |
MAP1LC3A |
microtubule associated protein 1 light chain 3 alpha |
multiple interactions |
EXP |
Deoxyglucose affects the reaction [demycarosyl-3D-digitoxosylmithramycin SK affects the expression of MAP1LC3A mRNA] |
CTD |
PMID:26079942 |
|
NCBI chr20:34,546,823...34,560,345
Ensembl chr20:34,546,854...34,560,345
|
|
G |
MAP1LC3B |
microtubule associated protein 1 light chain 3 beta |
multiple interactions increases prenylation |
EXP |
ATG7 protein promotes the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein]; Mannose inhibits the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein]; Oxygen deficiency inhibits the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein] |
CTD |
PMID:20593179 |
|
NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP |
Arsenic Trioxide inhibits the reaction [Deoxyglucose results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Deoxyglucose results in increased phosphorylation of and results in increased activity of MAPK1 protein; PQ 401 inhibits the reaction [Deoxyglucose results in increased phosphorylation of and results in increased activity of MAPK1 protein]; U 0126 inhibits the reaction [Deoxyglucose results in increased phosphorylation of and results in increased activity of MAPK1 protein] |
CTD |
PMID:23041229 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,754,500...21,867,680 Ensembl chr22:21,754,500...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO EXP |
MAPK3 protein affects the reaction [AICA ribonucleotide results in increased uptake of Deoxyglucose] arsenic trioxide inhibits the reaction [Deoxyglucose results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Deoxyglucose results in increased phosphorylation of and results in increased activity of MAPK3 protein; PQ 401 inhibits the reaction [Deoxyglucose results in increased phosphorylation of and results in increased activity of MAPK3 protein]; U 0126 inhibits the reaction [Deoxyglucose results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:11978788 PMID:23041229 |
|
NCBI chr16:30,114,105...30,123,309
Ensembl chr16:30,114,105...30,123,506
|
|
G |
METRNL |
meteorin like, glial cell differentiation regulator |
multiple interactions |
ISO |
METRNL protein inhibits the reaction [INS protein results in increased uptake of Deoxyglucose] |
CTD |
PMID:30213948 |
|
NCBI chr17:83,079,609...83,095,122
Ensembl chr17:83,079,609...83,095,122
|
|
G |
MMP13 |
matrix metallopeptidase 13 |
multiple interactions decreases expression |
EXP |
Deoxyglucose inhibits the reaction [IL1B protein results in increased expression of MMP13 protein]; Deoxyglucose inhibits the reaction [TNF protein results in increased expression of MMP13 protein] Deoxyglucose analog results in decreased expression of MMP13 protein |
CTD |
PMID:21211511 PMID:27931795 |
|
NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
decreases expression |
EXP |
Deoxyglucose analog results in decreased expression of MMP9 protein |
CTD |
PMID:27931795 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
multiple interactions |
EXP |
Deoxyglucose results in decreased phosphorylation of and results in increased expression of MTOR protein; Deoxyglucose results in increased phosphorylation of and results in increased activity of MTOR protein |
CTD |
PMID:23041229 PMID:23363784 |
|
NCBI chr 1:11,106,535...11,273,497
Ensembl chr 1:11,106,535...11,262,551
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
multiple interactions decreases expression |
EXP |
[demycarosyl-3D-digitoxosylmithramycin SK co-treated with Deoxyglucose] affects the expression of NFKB1 mRNA Deoxyglucose results in decreased expression of NFKB1 mRNA |
CTD |
PMID:26079942 |
|
NCBI chr 4:102,501,266...102,617,302
Ensembl chr 4:102,501,331...102,617,302
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
EXP |
Deoxyglucose promotes the reaction [STO 609 inhibits the reaction [Histamine results in increased phosphorylation of NOS2 protein]] |
CTD |
PMID:21145922 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NPY |
neuropeptide Y |
increases expression |
ISO |
Deoxyglucose results in increased expression of NPY mRNA |
CTD |
PMID:10683841 |
|
NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862
|
|
G |
OAT |
ornithine aminotransferase |
multiple interactions |
ISO |
Deoxyglucose inhibits the reaction [Cyclic AMP results in increased activity of OAT protein] |
CTD |
PMID:2827574 |
|
NCBI chr10:124,397,303...124,418,923
Ensembl chr10:124,397,303...124,418,976
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
EXP ISO |
Deoxyglucose inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein]; Deoxyglucose inhibits the reaction [Fenretinide results in increased cleavage of PARP1 protein] Deoxyglucose promotes the reaction [Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of PARP1 protein modified form]] Deoxyglucose results in increased cleavage of PARP1 protein |
CTD |
PMID:25246272 PMID:29095437 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,691...226,408,093 Ensembl chr 1:226,360,691...226,408,093
|
|
G |
PMCH |
pro-melanin concentrating hormone |
increases expression |
ISO |
Deoxyglucose results in increased expression of PMCH mRNA |
CTD |
PMID:10683841 |
|
NCBI chr12:102,196,459...102,199,540
Ensembl chr12:102,196,459...102,197,833
|
|
G |
PPARA |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
PPARA protein promotes the reaction [GW 7647 promotes the reaction [INS protein results in increased uptake of Deoxyglucose]] |
CTD |
PMID:21324916 |
|
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,756
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
affects uptake increases uptake |
ISO |
PPARG protein affects the uptake of Deoxyglucose PPARG gene polymorphism results in increased uptake of Deoxyglucose |
CTD |
PMID:18083318 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PPP3CA |
protein phosphatase 3 catalytic subunit alpha |
decreases response to substance |
ISO |
PPP3CA protein results in decreased susceptibility to Deoxyglucose |
CTD |
PMID:10679475 |
|
NCBI chr 4:101,023,418...101,348,295
Ensembl chr 4:101,023,409...101,348,278
|
|
G |
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
multiple interactions |
ISO |
RAF1 protein affects the reaction [AICA ribonucleotide results in increased uptake of Deoxyglucose] |
CTD |
PMID:11978788 |
|
NCBI chr 3:12,583,601...12,664,117
Ensembl chr 3:12,583,601...12,664,226 Ensembl chr 3:12,583,601...12,664,226
|
|
G |
RPS6 |
ribosomal protein S6 |
decreases phosphorylation |
EXP |
Deoxyglucose results in decreased phosphorylation of RPS6 protein |
CTD |
PMID:23363784 |
|
NCBI chr 9:19,375,715...19,380,236
Ensembl chr 9:19,375,715...19,380,236
|
|
G |
RPS6KB1 |
ribosomal protein S6 kinase B1 |
decreases phosphorylation multiple interactions |
EXP |
Deoxyglucose results in decreased phosphorylation of RPS6KB1 protein Deoxyglucose results in increased phosphorylation of and results in increased activity of RPS6KB1 protein; oxophenylarsine inhibits the reaction [Deoxyglucose results in decreased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:16183647 PMID:23041229 |
|
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
|
|
G |
SERPINB5 |
serpin family B member 5 |
increases expression |
EXP |
Deoxyglucose analog results in increased expression of SERPINB5 protein |
CTD |
PMID:27931795 |
|
NCBI chr18:63,476,958...63,505,085
Ensembl chr18:63,476,958...63,505,085
|
|
G |
SLC2A1 |
solute carrier family 2 member 1 |
multiple interactions increases uptake |
ISO EXP |
[arsenite affects the localization of SLC2A1 protein] which results in increased uptake of Deoxyglucose SLC2A1 protein results in increased uptake of Deoxyglucose SLC2A1 protein inhibits the reaction [INS protein results in increased uptake of Deoxyglucose] |
CTD |
PMID:2173694 PMID:14511371 |
|
NCBI chr 1:42,925,353...42,958,868
Ensembl chr 1:42,925,353...42,958,893 Ensembl chr 1:42,925,353...42,958,893
|
|
G |
SLC2A2 |
solute carrier family 2 member 2 |
multiple interactions increases transport |
EXP |
Cytochalasin B inhibits the reaction [SLC2A2 protein results in increased transport of Deoxyglucose]; Fructose inhibits the reaction [SLC2A2 protein results in increased transport of Deoxyglucose]; Glucose inhibits the reaction [SLC2A2 protein results in increased transport of Deoxyglucose]; Maltose inhibits the reaction [SLC2A2 protein results in increased transport of Deoxyglucose] |
CTD |
PMID:8457197 |
|
NCBI chr 3:170,996,341...171,026,721
Ensembl chr 3:170,996,347...171,026,743
|
|
G |
SLC2A3 |
solute carrier family 2 member 3 |
multiple interactions increases transport |
EXP |
Cytochalasin B inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose]; Galactose inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose]; Glucose inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose]; Maltose inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose] |
CTD |
PMID:8457197 |
|
NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...7,936,187
|
|
G |
SLC2A4 |
solute carrier family 2 member 4 |
multiple interactions increases uptake |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [mangiferin promotes the reaction [SLC2A4 protein results in increased uptake of Deoxyglucose]]; [arsenite affects the localization of SLC2A4 protein] which results in increased uptake of Deoxyglucose; mangiferin promotes the reaction [SLC2A4 protein results in increased uptake of Deoxyglucose]; Plant Extracts promotes the reaction [SLC2A4 protein results in increased uptake of Deoxyglucose] [Indinavir results in decreased activity of SLC2A4 protein] inhibits the reaction [resveratrol results in increased uptake of Deoxyglucose]; SLC2A4 promotes the reaction [INS1 protein results in increased uptake of Deoxyglucose]; SLC2A4 protein promotes the reaction [resveratrol results in increased uptake of Deoxyglucose] |
CTD |
PMID:14511371 PMID:18601907 PMID:19477051 PMID:20206685 |
|
NCBI chr17:7,281,718...7,288,257
Ensembl chr17:7,281,718...7,288,257
|
|
G |
SLC2A8 |
solute carrier family 2 member 8 |
increases uptake |
ISO |
SLC2A8 protein results in increased uptake of Deoxyglucose |
CTD |
PMID:23396969 |
|
NCBI chr 9:127,397,140...127,407,898
Ensembl chr 9:127,397,138...127,408,424
|
|
G |
SOD2 |
superoxide dismutase 2 |
multiple interactions |
EXP |
Deoxyglucose inhibits the reaction [manganese chloride results in increased expression of SOD2 mRNA]; Deoxyglucose inhibits the reaction [manganese chloride results in increased expression of SOD2 protein] |
CTD |
PMID:10328827 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529 Ensembl chr 6:159,669,069...159,762,529 Ensembl chr 6:159,669,069...159,762,529
|
|
G |
SQSTM1 |
sequestosome 1 |
multiple interactions |
EXP |
[bafilomycin A co-treated with Deoxyglucose co-treated with demycarosyl-3D-digitoxosylmithramycin SK] affects the expression of SQSTM1 protein; [bafilomycin A co-treated with Deoxyglucose] affects the expression of SQSTM1 protein; Deoxyglucose inhibits the reaction [demycarosyl-3D-digitoxosylmithramycin SK results in decreased expression of SQSTM1 mRNA]; Deoxyglucose promotes the reaction [demycarosyl-3D-digitoxosylmithramycin SK results in decreased expression of SQSTM1 mRNA] |
CTD |
PMID:26079942 |
|
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
|
|
G |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
increases expression |
ISO |
Deoxyglucose results in increased expression of SREBF1 mRNA |
CTD |
PMID:10913129 |
|
NCBI chr17:17,811,334...17,837,017
Ensembl chr17:17,810,399...17,837,011
|
|
G |
STK11 |
serine/threonine kinase 11 |
decreases phosphorylation |
EXP |
Deoxyglucose results in decreased phosphorylation of STK11 protein |
CTD |
PMID:23041229 |
|
NCBI chr19:1,205,778...1,228,431
Ensembl chr19:1,177,558...1,228,431 Ensembl chr19:1,177,558...1,228,431
|
|
G |
TNF |
tumor necrosis factor |
decreases expression multiple interactions decreases response to substance |
ISO EXP |
Deoxyglucose results in decreased expression of TNF protein Quercetin inhibits the reaction [TNF protein inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]]; TNF protein inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose] Deoxyglucose results in decreased susceptibility to TNF protein Deoxyglucose inhibits the reaction [TNF protein results in increased expression of MMP13 protein]; TNF protein inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]; Troglitazone inhibits the reaction [TNF protein inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]] |
CTD |
PMID:16483873 PMID:21211511 PMID:21778228 PMID:22713545 PMID:23439570 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions |
EXP |
[Deoxyglucose co-treated with demycarosyl-3D-digitoxosylmithramycin SK] results in increased expression of TP53 mRNA; Deoxyglucose promotes the reaction [demycarosyl-3D-digitoxosylmithramycin SK results in increased expression of TP53 mRNA]; TP53 protein inhibits the reaction [Deoxyglucose results in decreased abundance of Adenosine Triphosphate] |
CTD |
PMID:21042727 PMID:26079942 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538 Ensembl chr17:7,661,779...7,687,538
|
|
G |
XIAP |
X-linked inhibitor of apoptosis |
multiple interactions |
EXP |
[arsenic trioxide co-treated with Deoxyglucose] results in decreased expression of XIAP protein |
CTD |
PMID:23041229 |
|
NCBI chr X:123,859,708...123,913,972
Ensembl chr X:123,859,724...123,913,976 Ensembl chr X:123,859,724...123,913,976
|
|